Prolonged neonatal jaundice has been associated with breast feeding (1) (2) (3) (4) , but the clinical syndrome has not been fully described nor has the mechanism been elucidated. We have studied a syndrome of severe and prolonged unconjugated hyperbilirubinemia associated with breast feeding in seven full-term, unrelated, newborn infants. This report describes the clinical aspects of this syndrome and studies of its pathogenesis.
The transient unconjugated hyperbilirubinemia observed in all newborn infants during the first 5 days of life is usually referred to as physiologic hyperbilirubinemia and is believed to result from delayed development of the hepatic glucuronide conjugating system (5-7), particularly glucuronyl transferase (8) . Glucuronyl transferase catalyzes the transfer of glucuronic acid from uridine diphosphate glucuronic acid (UDPGA) to bilirubin and other receptors to form the corresponding glucuronides. Inhibition of glucuronyl transferase activity could theoretically result in unconjugated hyperbilirubinemia. The clinical observations suggested a relationship between mother's milk and the pathogenesis of the syndrome. We therefore studied the effect of milk from mothers of the seven jaundiced infants, from control mothers, and from pregnant and postpartum cows on glucuronyl transferase activity in vitro.
Methods
Seven full-term, breast-fed infants with severe, prolonged, and unexplained jaundice and their anicteric mothers were studied. Three cases were studied at the Bronx Municipal Hospital Center. Clinical and laboratory data for the four other patients were provided by referring pediatricians. Data regarding prenatal, perinatal, postpartum, and neonatal examinations, treatment, and medications were obtained from appropriate physicians and hospital records.
By conventional methods, the following examinations or tests were performed in each infant to exclude known causes of prolonged neonatal jaundice: hematocrit, hemoglobin, erythrocyte and leukocyte counts, peripheral blood morphology, Coombs test, and blood grouping; serum cephalin cholesterol flocculation, thymol turbidity, glutamic oxaloacetic and glutamic pyruvic transaminase activities, and estimations of the concentration of albumin and globulin; serologic examinations for syphilis; and blood cultures. Erythrocyte glucose-6-phosphate dehydrogenase activity was estimated in four infants, and the urinary sediment was studied in three cases for evidence of cytomegalic inclusion body disease.
Serum total and direct-reacting bilirubin concentrations were estimated according to the method of Malloy and Evelyn (9) . In five cases, plasma bile pigments were coupled with diazotized sulfanilic acid, and the resulting dipyrrol azopigments were characterized chromatographically according to Schmid (10) . Mother's milk was collected manually or with the aid of a breast pump and was frozen until examined.
Forty-eight specimens of milk and three specimens of colostrum were obtained from the mothers of the seven jaundiced infants from postpartum days 2 to 35. Ninetynine specimens of milk were obtained from 71 women whose infants did not demonstrate prolonged jaundice. Thirty-two specimens of milk were freshly obtained from ten Guernsey, eight Jersey, and six Holstein cows during various stages of pregnancy and the postpartum period. These specimens were also frozen until examined.
Adult male Wistar rats, New Zealand white rabbits, and Hartley guinea pigs were obtained from a single supplier and killed as needed by decapitation; the livers were removed rapidly and placed in ice-cold isotonic KCl before tissue preparations were made. Human liver was obtained at surgery for diseases not involving the liver or biliary tract and was treated identically as the animal liver. All subsequent operations were performed at 0 to 40 C. Liver was blotted and slices were prepared with a Stadie blade. Twenty-five to 50 mg of liver slices was placed in each flask for incubation. Ten per cent liver homogenates were prepared in 0.25 M sucrose in a glass homogenizer with a motor driven Teflon pestle. Microsomal fractions were prepared according to Hogeboom's technique (11) .
Frozen human and cow's milk was thawed to 20°C and mixed manually with a loosely fitting glass homogenizer. If necessary, the pH was adjusted to 7.3 to 7.4 with 0.1 N NaOH or 0.1 N HCl. Levvy and Storey (12) . Direct-reacting bilirubin formation by slices and homogenates of guinea pig, rat, rabbit, and human liver was estimated in quadruplicate according to the technique of Lathe and Walker (13) with and without the addition of human or cow's milk (0.2 ml). UDPGA was added in excess when homogenates and microsomes were studied but was not added to liver slices. Inhibition was estimated by comparing the formation of o-aminophenol glucuronide or direct-reacting bilirubin by tissue preparations in the presence and absence of human or cow's milk in vitro.
The effect of milk from three mothers of jaundiced infants and from three mothers of normal infants on o-aminophenol glucuronide formation by guinea pig liver homogenates was studied after storage of milk in the dark at 200 C for 6 weeks; after immersion of 10 ml of milk in a boiling water bath for 1 hour, cooling to room temperature, and gentle mixing with a loosely fitting glass homogenizer; and after dialysis in the dark at 4°C against flowing isotonic saline for 5 days. From 75 to 450 ml of milk was separately collected from each of the following: 1) three mothers of the seven jaundiced infants, 2) two mothers whose milk was approximately 20% inhibitory and whose infants were normal, and 3) three mothers whose milk was not inhibitory and whose infants were normal. Milk was stored at -200 C and slowly thawed. The cream layer was separated and saponified by heating in alkali (0.5 ml 60%o KOH per g milk fat) at 100°C for 1 hour. The alkaline digest was repeatedly extracted with ether; the extracts were pooled, and the ether evaporated. The residue was taken up in a small volume of dry methanol with vigorous shaking and warming if necessary. From 100 to 300 dul of each sample was placed on separate, freshly prepared, thin layers of silica gel G spread on glass plates. Ascending chromatography was performed with chloroform/methanol/water (75/25/4, vol/vol/vol) as a developing system. Duplicate chromatograms were prepared, one of which was sprayed with sulfuric acid for identification of zones of organic material. From the other chromatogram 1.5-to 3.0-cm zones of silica gel were scraped starting at the solvent front. Each fraction was eluted with 1 ml of 90% methanol in water. The gel was centrifuged and washed twice with 0.5-ml portions of 90% methanol, and the washes were pooled with the eluates. Eluates from identical zones of several chromatograms were pooled, methanol was evaporated, and the eluates were further dried in vacuo over anhydrous CaSO4 and paraffin shavings. The resulting crystalline material was identified by infrared spectrometry and gas-liquid and thin-layer (Figure 1) . § Mother temporarily stopped breast feeding for 5 days (Figure 2 ). Kinetic studies were performed using o-aminophenol as a glucuronide receptor, guinea pig liver microsomes, and authentic pregnane-3(alpha), 20(beta)-diol and pregnane-3(alpha), 20(alpha)-diol. These steroids were dissolved in 55% ethanol and added to incubation flasks in a final concentration of 1.1 X 10-M. The resulting data were plotted according to the method of Lineweaver and Burke (14) .
Serum was obtained from six of the seven mothers of jaundiced infants from days 10 to 26. The inhibitory effect of these sera on o-aminophenol glucuronide formation by guinea pig liver homogenates and direct-reacting bilirubin formation by rat liver slices was studied according to the techniques of Hsia, Dowben, Shaw, and Grossman (15) and of Lathe and Walker (13), respectively. The results were compared with those obtained with 17 samples of sera from 15 mothers of anicteric infants during the same postpartum period.
Results
Clinical and laboratory data pertaining to the seven jaundiced infants and their anicteric mothers are presented in Tables I and II . The mothers' pregnancies were considered normal; no known hepatotoxic drugs or hormones were administered, and deliveries were uncomplicated and occurred either without anesthesia (one case), with Demerol and scopolamine (three cases), or with promazine hydrochloride and nitrous oxide (three cases).
The four male and three female babies were full term (birth weights, 2,740 to 3,940 g), and each had an uncomplicated birth. Breast feeding began on the second or third day of life. Each baby thrived. Mild jaundice was noted in four cases during the first 4 days of life; serum bilirubin concentrations were not estimated, and a diagnosis of physiologic hyperbilirubinemia was made. Mothers and babies were discharged from the hospital between the fourth and seventh days. Progressively increasing jaundice was observed by each mother in her infant, and rehospitalization of five babies occurred on days 9 to 14. Two mothers and their infants were examined at the hospital but remained at home under medical care. Examination of the babies revealed intense jaundice of the skin and sclerae but no hepatomegaly, splenomegaly, fever, pallor, or neurologic changes. During the subsequent 4 to 8 days, breast feeding was continued, and appropriate laboratory studies were performed to determine the etiology of the jaundice. The results of these studies were normal. The maximal serum unconjugated bilirubin concentrations ranged from 14.3 to 24.5 mg per 100 ml and were observed on the tenth to the nineteenth days of life (Table I ). The serum directreacting bilirubin concentration did not exceed 10%o of the total bilirubin concentration in any case. In five cases, chromatographic study of the dipyrrol azopigments revealed only azopigment A, the unconjugated azopigment. Breast feeding was abruptly ter infants (Table I ). The serum b tration was estimated at 1-to 3-dz became normal in 3 to 6 days. OG nated breast and bottle feeding of h( and the serum bilirubin concentrat mal in 12 days. The mother of 1 tinued breast feeding her infant jaundice ( Figure 1 ). The serun centration was 17 mg per 100 ml day of life, 7.5 mg per 100 ml on day, and normal on the thirty-I mother of baby L. M. breast fed he second to the ninth days, at which serum bilirubin concentration was ml ( Figure 2 ). Breast feeding M for 4 days, evaporated milk was sub mother manually collected her mil serum bilirubin concentration d( mg per 100 ml within 4 days. 0 day of life breast feeding was re infant's serum bilirubin concentrate 5.0 to 5.8 mg per 100 ml for 5 dmg per 100 ml on the twentieth d
The seven mothers were unrela Jewish (three cases), Italian (twi (one case), and Chinese (one (Table II) The duration of inhibition of o-aminophenol n bilirubin con-glucuronide formation in vitro was studied in milk on the eleventh from two mothers with jaundiced infants (Figure  the twenty-first 4) . The mother of baby A.M. continued to nurse fifth day. The her infant, whose serum bilirubin concentration zr baby from the slowly decreased to normal by day 35 (Figure 1 The effect of milk from seven mothers with rabbit liver is presented in Table III . Directjaundiced infants and from control mothers on reacting bilirubin production by liver homogenates the formation of direct-reacting bilirubin by slices from each species exceeded that by slices of comand homogenates of human, guinea pig, rat, and parable wet weight from the same species. The Table IV . Each frachibited o-aminophenol glucuronide formation by tion was reconstituted with isotonic sodium chlo-9 + 4.3% (SD) and direct-reacting bilirubin for-ride to its original volume and tested with conmation by 11 ± 3.6% (SD).
trols. Thirty-five per cent of the inhibitory ac- Figure 5 ). Gasliquid chromatography of the isolated crystalline material was consistent with this identification (Table V) . Figure 6 is a representative thinlayer chromatogram of the ether extract of the alkaline digest of an inhibitory breast milk from the baby A.M. The chromatogram was sprayed with sulfuric acid to locate organic material. The inhibitory zone of the patient's milk eluate demonstrates a spot that migrates the same as pregnane-3(alpha), 20(beta)-diol.
In Figure 7 , the effects of equimolar amounts of authentic pregnane-3 (alpha), 20(alpha) -diol by rapid disappearance of hyperbilirubinemia after cessation of breast feeding; by absence of severe jaundice in bottle-fed siblings; and, in one case, by rapid decrease in hyperbilirubinemia when artificial feeding was temporarily substituted for breast feeding and subsequent prolonged hyperbilirubinemia when breast feeding was reinstituted. Drugs or acquired diseases are unlikely etiologic factors because the syndrome was observed in 13 of 14 breast-fed infants of the seven mothers over an 8-year period. The role of inherited factors in the pathogenesis of the syndrome is uncertain because the seven mothers represent four different ethnic groups, and none of their sisters, mothers, or grandmothers had children with severe and prolonged jaundice clinically associated with breast feeding. Jaundice in each infant was minimal during the first 5 days of life and was attributed to physiologic hyperbilirubinemia. Severe clinical icterus was not apparent until the seventh to tenth days. \Vlhether physiologic hyperbilirubinemia persisted in these infants is not known, as serum bilirubin levels were not serially estimated and the cases were discovered in retrospect. Despite subsequent serum unconjugated bilirubin concentrations of 14.7 to 24.5 mg per 100 ml, neither signs nor symptoms of kernicterus were seen, probably because the blood brain barrier was already impermeable to unconjugated bilirubin (16) .
Milk obtained from the mothers of the seven jaundiced infants after the third postpartum day consistently inhibited glucuronyl transferase activity in vitro, whereas three specimens of colostrum did not. Apparently the inhibitor is not present in colostrum and appears when true lactation begins on the third to fifth postpartum days. This observation may account for the apparent absence of severe hyperbilirubinemia during the first 5 days of life.
In etiology, this syndrome differs from other recognized conditions of severe, prolonged, nonhemolytic, unconjugated hyperbilirubinemia in fullterm infants. An inherited homozygous deficiency in hepatic glucuronyl transferase results in the Crigler-Najjar syndrome (17) (18) (19) (15) . A variety of synthetic progestational steroids inhibit glucuronyl transferase in-vitro. This action may play a role in the jaundice associated with their administration, although a major functional effect on hepatic excretory transport has also been demonstrated (24) (25) . Neither progesterone nor pregnanediol have been previously associated with jaundice.
Equimolar amounts of pregnane-3 (alpha), 20 (alpha) -diol and pregnane-3 (alpha), 20 (beta) -diol equally and competitively inhibit glucuronyl transferase activity in vitro. These steroids may act in a similar fashion in vivo. Normally occurring delayed development of hepatic glucuronyl transferase activity in the newborn guinea pig appears to limit the over-all transfer of bilirubin from blood to bile in vivo (26) . If the same occurs in human infants, a suitable environment is created for an inhibitor of glucuronyl transferase to produce severe and prolonged jaundice. This postulate is supported by the observation that oral administration of pregnane-3 (alpha), 20 (beta) -diol (1 mg per day) to two full-term infants beginning on the sixth and eighth days resulted in reversible unconjugated hyperbilirubinemia unrelated to hemolysis or liver damage (27) . There appears to be nothing unique about the infants of mothers who secrete pregnane-3 (alpha), 20(beta) -diol in their milk, as hyperbilirubinemia will prob-ably develop in any newborn infant after administration of the steroid. Normally occurring delayed development of glucuronyl transferase activity and competitive inhibition in vivo appear to be major mechanisms in the pathogenesis of the syndrome.
Milk from pregnant and postpartum cows was not significantly inhibitory in vitro. This is consistent with the observation that less than 0.06% of administered progesterone-C14 is excreted in milk from pregnant cows in 48 hours (28) .
The source of pregnane-3(alpha), 20(beta)-diol in the mothers' breast milk is unknown. Progesterone formation is believed to cease with expulsion of the placenta (29) . There was no clinical evidence of retention of placental tissue in the mothers studied. Pregnanediol excretion in the urine normally decreases rapidly after delivery and virtually disappears by the third postpartum day (30) . Milk remained inhibitory for more than 4 weeks in the two women who continued to nurse their babies.
Pregnane-3(alpha), 20(beta)-diol has not been demonstrated in human tissues, although it is a major progesterone metabolite in guinea pigs and cattle. Review of the literature reveals that the presence of this isomer in human tissues has not been intensively investigated.
At the same time as the mothers' milk strongly inhibited glucuronyl transferase activity in vitro, their sera were not more inhibitory than normal postpartum sera. These observations suggest that the serum concentration of pregnanediol is not greatly increased. Whether pregnane-3(alpha), 20(beta)-diol is synthesized in the breast before lactation and subsequently slowly released, or is synthesized in nonmammary tissue and concentrated in the breast either before or during lactation, is not known. Radioautographic studies in rabbits and goats demonstrate marked uptake of progesterone-C14 or its metabolites in lactating mammary glands (31) .
Summary
A syndrome of severe and prolonged unconjugated hyperbilirubinemia has been described in association with breast feeding in seven unrelated full-term infants.
Milk obtained from the mothers of the seven infants consistently inhibited glucuronyl transferase activity in vitro when compared with 99 specimens of milk obtained from 71 women whose infants did not demonstrate this syndrome.
A steroid that competitively inhibits glucuronyl transferase activity in vitro has been isolated from inhibitory but not from noninhibitory human milk. The steroid has been identified as pregnane-3(alpha), 20(beta)-diol. The precursor of pregnane-3 (alpha), 20(beta) -diol, the mechanisms responsible for its presence in human milk, and the significance of the unusual isomer are uinknowvn and require further study.
